Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2007

Mar 1, 2007

30339_dirs_2007-03-01_c2cd8ca6-7479-4bee-8cee-5503ef343f7e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2007-02-27

Reporting Person: Paproski John E (Vice President - Innovations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-02-27 Common Stock A 2245 $44.9700 Acquired 16557.7590 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-02-27 Stock Option (Right to Buy) $44.9700 A 8780 Acquired 2018-02-27 Common Stock (8780.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 5661.1837 Indirect

Footnotes

F1: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2004 that have vested for performance period III.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.